“#Vaccines and treatments for #SARSCoV2 have reduced the morbidity and mortality associated with SARS-CoV-2 infections for the majority of the population, but there remain important subgroups that continue to be at elevated risk for severe disease and death, including #OlderAdults, people who have #immunocompromising conditions, and people who have severe #coexisting conditions, such as #ChronicLungDisease or #HeartDisease.”